我国首个同位素生产技术品牌“和福一号”项目再次传来喜讯——经三批次辐照提纯与试用验证中核集团旗下中国核电投资控股秦山核电

智通财经
25 Jun
我国首个同位素生产技术品牌“和福一号”项目再次传来喜讯——经三批次辐照提纯与试用验证中核集团旗下中国核电投资控股秦山核电基地依托商用重水堆生产的镥-177正式供应市场年辐照产能超万居里可完全满足全国市场需求。这标志着我国继碳-14规模化供应、钇-90具备规模化辐照生产能力后在医用同位素自主生产领域实现的又一关键突破。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10